MPH Health Care AG
MPH Health Care AG (0W1Q.L) Stock Overview
Explore MPH Health Care AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
80.7M
P/E Ratio
2.52
EPS (TTM)
$-2.09
ROE
0.11%
0W1Q.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of MPH Health Care AG (0W1Q.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 37.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $23.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 2.52 and a market capitalization of 80.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.
Patrick Brenske
2
GrUenauer Strasse 5, Berlin
2018